Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
LLY
Eli Lilly and Company
Lilly is a large, diversified global pharmaceutical company with a core high-revenue portfolio.
|
$1.01T |
$1059.11
+3.08%
|
|
JNJ
Johnson & Johnson
Johnson & Johnson's portfolio includes multiple monoclonal antibody therapeutics (e.g., DARZALEX, CARVYKTI, TECVAYLI, TALVEY) across oncology and immunology.
|
$515.79B |
$214.70
+1.47%
|
|
ABBV
AbbVie Inc.
AbbVie directly commercializes monoclonal antibody therapeutics (e.g., Skyrizi) as a core immunology asset.
|
$394.51B |
$227.13
+1.71%
|
|
UNH
UnitedHealth Group Incorporated
UNH is primarily a health insurer and provides medical benefit plans through UnitedHealthcare.
|
$309.60B |
$342.35
+0.15%
|
|
AZN
AstraZeneca PLC
AZN is a large-cap pharmaceutical company with a diversified, global drug portfolio and a robust R&D pipeline.
|
$283.84B |
$91.45
+1.81%
|
|
MRK
Merck & Co., Inc.
The company markets vaccines (Capvaxive) and has historical Gardasil sales, making vaccines a core product category.
|
$250.53B |
$99.92
-0.37%
|
|
NVO
Novo Nordisk A/S
Novo Nordisk is a leading large-cap pharmaceutical company with blockbuster GLP-1 products Wegovy and Ozempic, a core driver of its revenue and growth.
|
$226.31B |
$50.35
+0.34%
|
|
ABT
Abbott Laboratories
Abbott's cardiology device portfolio includes leadless pacemakers (AVEIR), MitraClip/TMVR systems and other interventional devices, representing core revenue drivers in Cardiology Devices.
|
$218.36B |
$128.61
+2.51%
|
|
TMO
Thermo Fisher Scientific Inc.
Thermo Fisher directly manufactures and sells diagnostic instruments and equipment used in clinical labs.
|
$216.10B |
$574.43
+0.38%
|
|
ISRG
Intuitive Surgical, Inc.
Intuitive Surgical directly manufactures robotic surgical systems and instruments, i.e., core surgical equipment.
|
$200.57B |
$559.95
+3.25%
|
|
AMGN
Amgen Inc.
Amgen's portfolio includes monoclonal antibody therapeutics such as Repatha and tezepelumab (TEZSPIRE).
|
$175.13B |
$324.44
+2.11%
|
|
DHR
Danaher Corporation
Danaher directly sells diagnostic equipment/instruments (e.g., Cepheid and Beckman Coulter diagnostics platforms like DxC 500i, DXi 9000).
|
$162.06B |
$227.24
+0.40%
|
|
PFE
Pfizer Inc.
Pfizer is a Large Cap Pharma company, reflecting its scale and diversified pharma-centric revenues.
|
$150.27B |
$26.54
+2.67%
|
Showing page 1 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
